COVID Delays Leave Nearly 2,000 Drug Plants
As COVID-19 swept across the globe in early 2020, the Food and Drug Administration pulled most of its safety inspectors from ...
The leadership change comes after psychedelic drugmaker Lykos lost its bid for FDA approval.
Harris touts the IRA's drug pricing measures which reduce Medicare beneficiary out-of-pocket costs. If elected her quest to ...
The production limit for lisdexamfetamine was increased by 6,236 kilograms, which includes 1,558 kg to address increased ...
Listeria contamination is causing meats and produce to be pulled off store shelves nationwide, with hospitalizations and deaths continuing ...
Newsweek magazine delivered to your door Newsweek Voices: Diverse audio opinions Enjoy ad-free browsing on Newsweek.com Comment on articles Newsweek app updates on-the-go ...
August 22, 2024, 2:35 PM ESTCommercial Real Estate December 14, 2022, 3:14 AM ESTHealth Care August 12, 2022, 2:46 PM ESTHealth Care June 24, 2022, 11:37 AM ESTHealth Care October 21, 2021, 12:22 ...
Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough ...
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) and Shilpa Medicare Limited (“Shilpa”) announced U.S. Food and Drug Administration (FDA) approval of BORUZU ™, a new ...
The state's lawmakers have passed a first-of-its-kind bill that would ban six artificial dyes from the foods served in its canteens - which have been linked to low IQ, behavioral problems and even ...
At least two in five U.S. adults under the age of 65 with "private insurance could be eligible under clinical criteria for GLP-1 drugs," a new KFF analysis shows.
Moderna, Inc. (NASDAQ:MRNA) today announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of the COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results